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This article brieﬂy describes our own experience with the proven demonstration of heat
shock protein 70 (HSP70) in reperfused renal allografts from brain-dead donors and reﬂects
about its potential role as a typical damage-associated molecular pattern (DAMP) in the
setting of innate alloimmunity. In fact, our group was able to demonstrate a dramatic up-
regulation of HSP70 expression after postischemic reperfusion of renal allografts. Of note,
up-regulation of this stress protein expression, although to a lesser extent, was already
observed after cold storage of the organ indicating that this molecule is already induced
in the stressed organism of a brain-dead donor. However, whether or not the dramatic up-
regulation of HSP70 expression contributes to mounting an innate alloimmune response
cannot be judged in view of these clinical ﬁndings. Nevertheless, HSP70, since generated
in association with postischemic reperfusion-induced allograft injury, can be called a typical
DAMP – as can every molecule be termed a DAMP that is generated in association with
any stressful tissue injury regardless of its ﬁnal positive or negative regulatory function
within the innate immune response elicited by it. In fact, as we discuss in this article,
the context-dependent, even contradistinctive activities of HSP70 reﬂect the biological
phenomenon that, throughout evolution, mammals have developed an elaborate network
of positive and negative regulatory mechanisms, which provide balance between defen-
sive and protective measures against unwarranted destruction of the host. In this sense,
up-regulated expression of HSP70 in an injured allograft might reﬂect a pure protective
response against the severe oxidative injury of a reperfused donor organ. On the other
hand, up-regulated expression of this stress protein in an injured allograft might reﬂect
a (futile) attempt of the innate immune system to restore homeostasis with the aim to
eliminate the “unwanted foreign allograft invader” by contributing to development of an
adaptive alloimmune response. However, this adaptive immune response against donor
histocompatibility alloantigens – in its evolutionary sense aimed to restore homeostasis –
is by no means protective from a recipient’s view point but tragically ends up with allograft
rejection. Indeed: in this sense, allograft rejection is the result of a fateful confusion by the
immune system of danger and beneﬁt!
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INTRODUCTION: ALLOGRAFT INJURY-INDUCED INNATE
ALLOIMMUNITY
FIRST CLUE TO THE EXISTENCE OF INNATE ALLOIMMUNITY: THE
INJURY HYPOTHESIS (1994)
Originally, the immune system was regarded as a host defense
system that is primarily directed against invading pathogens with
the aim to prevent/cure infection. Following the re-discovery of
innate immunity in the mid/late 1990s, this concept was con-
ﬁrmed and extended: Infection of cells by microorganisms was
seen to activate the innate immune system that elicits an inﬂam-
matory response merging into an adaptive immune response. The
initial sensing of infection was recognized to be mediated by pat-
tern recognition receptors (PRRs) in/on innate immune cells that
play a pivotal role in the ﬁrst line of this host defense system.
PRRs were found to recognize distinct pathogen-derived motifs,
the pathogen-associated molecular patterns (PAMPs) to initiate
and regulate innate and adaptive immune responses (for review,
see Kumar et al., 2011).
First notions that the immune system has evolved the capacity
to detect any tissue injury in ways that stimulate the initiation
and generation of adaptive immune responses to antigens were
addressed and discussed by two hypotheses nearly simultane-
ously published early in 1994 (Land et al., 1994; Matzinger, 1994).
These two hypotheses postulated that the adaptive immune system
evolved to respond not only to pathogen-mediated “infectious”
tissue injury per se but also to non-physiological cell death, tissue
injury, or stress, as, for example, mediated by postischemic reper-
fusion injury (IRI). As a matter of fact, it was Matzinger (1994)
who proposed her famous “Danger Hypothesis.” Her model –
proposed on theoretical grounds – suggested that the primary
driving force of the immune system is the need to detect and
protect against danger. Danger, however, equals tissue destruc-
tion, that is, tissue injury. Our “Injury Hypothesis” – proposed
on statistically signiﬁcant data from a prospective clinical trial
in kidney transplant patients (the “Munich SOD Trial”) – dis-
cussed the possibility that it is the primary injury to an allograft
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that – via activation of antigen-presenting cells – induces path-
ways leading to an adaptive alloimmune response (Land et al.,
1994). In fact, this hypothesis was based on our pivotal clinical
observation that (antioxidative) treatment of a non-speciﬁc tis-
sue injury [here: the reactive oxygen species (ROS)-mediated IRI
to allografts] leads to a signiﬁcant reduction in subsequent spe-
ciﬁc, adaptive immunity-mediated processes (here: reduction of
alloimmune-mediated allograft rejection).
Under the line, the two hypotheses postulated the same sce-
nario: The initial tissue injury, that is, the injurious inﬂammatory
tissue environment, alerts the immune system, and is a manda-
tory prerequisite to mount an efﬁcient adaptive immune response
against foreign antigens.
ROLE OF DAMAGE-ASSOCIATED MOLECULAR PATTERNS AND PATTERN
RECOGNITION RECEPTORS IN OXIDATIVE INJURY – INDUCED
ALLOGRAFT (“STERILE”) INFLAMMATION
Over the past decade, increasing evidence has been published in
support of thenotion that PRRs recognize non-infectious but inju-
rious agents that can cause tissue damage (for reviews, see: Beutler,
2007; Manfredi et al., 2009; Chen and Nuñez, 2010; Bauernfeind
et al., 2011; Jaeschke, 2011; Yanai et al., 2011). In this scenario,
PRRs sense injury-induced, host-derived endogenous molecules
in terms of damage-associated molecular patterns, that is,DAMPs,
an acronym that was coined by us in analogy to PAMPs 8 years ago
(Land, 2003a). These DAMPs are released following tissue injury
or cell death and have similar functions as PAMPs in terms of their
ability to activate pro-inﬂammatory pathways in innate immune
cells.
Of note, ROS-mediated IRI to allografts can be regarded as
a model of a non-pathogen-induced oxidative tissue injury that
activates the innate immune system. In fact, an emerging role of
innate immune events in adaptive alloimmunity-mediated allo-
graft rejection (= innate alloimmunity) has been noted (for
reviews, see Land, 2011a,b). However, the situation in the allograft
setting is more complex as two individually different categories of
DCs are involved: (1) donor-derived PRR-bearing innate immune
cells such as DCs, vascular, and epithelial cells already residing
in the transplant and (2) recipient-derived PRR-bearing innate
immune cells such as DCs and neutrophils invading the allograft
during reperfusion in the recipient. Moreover, various DAMPs
such as high mobility group box 1 (HMGB1) and heat shock pro-
tein 70 (HSP70) are generated already in the brain-dead organ
donor (Arbogast et al., 2002; Krüger et al., 2009; Kaminska et al.,
2011), however, their up-regulated expression culminate during
allograft reperfusion in the recipient (Arbogast et al., 2002; Kac-
zorowski et al., 2009; Klune and Tsung, 2010). Indeed, according to
new insights into mechanisms of innate immunity, a brain-dead
organism, characterized by the demonstration of DAMPs, PRRs,
and circulating cytokines, may be deﬁned as an acute systemic
innate immunity-mediated autoinﬂammatory syndrome (Land,
2011b). To add yet another level of complexity in the allograft
setting, it can be assumed that further DAMPs are released from
necrotic cells caused by allograft reperfusion injury which may
include nucleic acids, oxidation-speciﬁc DAMPs such as thiore-
doxin (TRX)-interacting protein (TXNIP) and purine metabolites
such as ATP (Schröder et al., 2010; Bours et al., 2011; Kis-Toth
et al., 2011). In addition to those DAMPs derived from an intra-
cellular source, IRI leads to release of extracellular located DAMPs
such as extracellular matrix fragments including hyaluronan and
heparan sulfate. The prototypical PRRs recognizing all those var-
ious DAMPs include Toll-like receptors (TLRs) such as TLR2
and TLR4 and the receptor for advanced glycation end-products
(RAGE) as well as PRRs able to recognize nucleic acids such as
RIG-I-like receptors (RLRs) and AIM2-like receptors (for review,
see Land, 2011e).
There is a special role for the cytosolic nucleotide-binding
domain leucine-rich repeats (NLR) receptors because one of its
members represents the core structure of theNOD,LRR,andpyrin
domain-containing 3 (NLRP3) inﬂammasome, the most widely
studied inﬂammasome now known to be activated by various
DAMPs (for review, see Bauernfeind et al., 2011). In fact, the well-
known creation of “sterile” inﬂammation in reperfused organs
(and solid allografts have to be included here) is now believed to
be induced by inﬂammasomes. Most important in regard to the
topic of IRI are recent studies in both Nlrp3- and ASC-deﬁcient
mice clearly demonstrating that the NLRP3 inﬂammasome con-
tributes to the IRI-mediated acute inﬂammatory response (Iyer
et al., 2009). These studies revealed that non-lethal renal IRI
results in a signiﬁcant up-regulation of Nlrp3 gene expression,
which is accompanied by pronounced acute tubular necrosis that
is similar between wild-type (WT) and Nlrp3-deﬁcient animals.
Importantly, the studies showed that Nlrp3-deﬁciency protected
animals from lethal renal IRI. Similarly, ASC-deﬁciency protected
animals from lethal renal IRI, although the difference, com-
pared to WT mice, was less pronounced than in Nlrp3-deﬁcient
mice.
Activation of the NLRP3 inﬂammasome is currently thought to
consist of two steps: a ﬁrst priming step that consists of stimulation
of PRRs which leads to the up-regulation of NLRP3 expression
and also induces pro-IL-1β expression. Stimuli priming NLRP3
appear to include all ligands for TLRs,RLRs, andNLRs, that lead to
enhanced NLRP3 expression (Bauernfeind et al., 2011). Thus, the-
oretically,HSP70, as a ligand of TLR4 and TLR2, can be counted to
those priming DAMPs (The LPS-contamination debate in regard
to TLR2 and TLR4 is not dealt with here but discussed elsewhere;
Land, 2011e). The second step consists of the activation of NLRP3
itself which is distinct from this initial priming step. Three pre-
sumably distinct pathways have been postulated that can lead to
the activation of NLRP3 (activation step): (1) extracellular ATP
that is often seen to be largely increased during cell death, can
bind to purinergic receptor P2X7 and leads to NLRP3 activation
via ion ﬂux effects (including intracellular K+ depletion) medi-
ated by the P2X7-receptor-associated hemi-channel pannexin-1;
(2) endocytosis of sterile particulates, such as cholesterol crystals,
resulting in lysosomal disintegration which leads to the leakage
of lysosomal enzymes into the cytosol (activation of the protease
cathepsin B); and (3) generation of ROS during cellular stress or
death leading to the activation of NLRP3 through the release of
TXNIP from thioredoxin and then binds to NLRP3 (for review, see
Bauernfeind et al., 2011). Although the role of ROS in NLRP3 acti-
vation is still not quite clear, this potential activation mechanism is
of considerable attraction in regard to ROS-mediated reperfusion
injury to allografts.
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ALLOGRAFT INJURY-INDUCED, DAMPs-MEDIATED GENERATION OF
DONOR- AND RECIPIENT-DERIVED IMMUNOSTIMULATORY DCs
In fact, growing evidence suggests that allograft injury induces
innate immune events which precede adaptive alloimmunity.
Within an innate immune-mediated intragraft inﬂammatory
milieu, donor- and recipient-derived DCs get activated, migrate
to the secondary lymphoid tissue of the recipient to translate
innate immunity to an adaptive alloimmune response. The gen-
eration of these immunostimulatory DCs is the result of innate
immunepathways initiated and induced by variousDAMPswhich,
as reviewed (Land, 2011b), may be divided into four different
classes of DAMPs: (1) class I DAMPs such as HMGB1 and HSP70
that, when recognized by PRRs of immature DCs (iDCs), trigger
their activation to immunostimulatory DCs; (2) class II DAMPs
such as MHC class I chain-related molecules A and B that, when
recognized by special activating receptors (NKG2D) on innate
lymphocytes may contribute to generation of immunostimula-
tory DCs in terms of a cross-talk; (3) class III DAMPs such as
TXNIP and extracellularATP that are recognized by PRRs involved
in the activation of the NLRP3 inﬂammasome, and (4) class IV
DAMPs in terms of neoantigens that are recognized by pre-existing
natural immunoglobulin M antibodies, which – via complement
activation – are able to aggravate the oxidative tissue injury and,
thereby, may indirectly promote metamorphosis of iDCs into
immunostimulatory DCs.
In fact, there seems to be a complex collaboration between
various membrane-bound and cytosolic PRRs on one side and
their different cognate DAMPs on the other side which results in
those well-known vigorous innate alloimmune responses. Most
likely, this complex orchestration of intragraft DAMP–PRR inter-
actions may ﬁnely regulate the maturation process of donor- and
recipient-derived iDCs into immunostimulatory DCs, that, via
processes of direct and indirect allorecognition, may stimulate
naïve T cells of the recipient, thereby mounting, and ﬁne-tuning
adaptive alloimmune responses of various intensities.
ROLE OF HEAT SHOCK PROTEIN 70 IN INNATE
ALLOIMMUNITY
DONOR BRAIN DEATH-MEDIATED AND REPERFUSION
INJURY-INDUCED UP-REGULATION OF HSP70 EXPRESSION IN HUMAN
ALLOGRAFTS
The ﬁrst DAMP shown to be involved in the setting of clinical
organ transplantation was the inducible HSP70 that was up-
regulated following renal allograft reperfusion injury, that is, a con-
dition in which contamination with pathogen-derived exogenous
ligands of PRRs can be totally ruled out (Arbogast et al., 2002). In
fact, our group was able to demonstrate a dramatic up-regulation
of HSP70 expression after postischemic reperfusion of renal allo-
grafts fromdeceased (brain-dead) donors (Figure 1). Interestingly,
up-regulation of HSP70 expression, although to a lesser extent,
was already observed after cold storage of the organ indicating
that this stress protein is already induced in the stressed organism
of a brain-dead donor (Figure 1). These ﬁndings prompted us to
discuss a role of HSP70 in innate alloimmunity by proposing that
HSPs (1) in their function as endogenous ligands of TLRs may
lead to DC maturation and (2) in their function as chaperokines
may facilitate cross-presentation of HSP-chaperoned allopeptides
FIGURE 1 | Immunohistochemical demonstration of expression of the
inducible heat shock protein 70.The renal biopsy specimen shows a
human kidney removed from a brain-dead donor, perfused with the
University Wisconsin preservation solution, and cold-stored over 13 h. The
biopsy was taken before (right) and 60min after reperfusion (left) following
implantation into the recipient. Demonstration was performed using the
monoclonal antibody HSP 6B3 (GSF, non-commercially available), speciﬁc
for inducible heat shock component HSP 70 (formerly HSP72c) in a dilution
of 1:150, at room temperature, for 1 h. A detection system APAAP (alkaline
phosphatase–antialkaline phosphatase) from the rat (Fa Dako) is used, by
incubation with linking antibody and staining with fast red. Sources: Further
properties (e.g., speciﬁcity) of the monoclonal antibodies are described in:
Milani et al. (2002) and Arbogast et al. (2002). Permission: Reproduced with
permission of: Land WG. Innate Alloimmunity, Part 2. Innate Immunity and
Allograft Rejection, and Bas¸kent University, Pabst Science Publishers, 2011.
on MHC class I molecules of recipient-derived DCs (Land, 2002,
2003b). Whether or not dramatic up-regulation of HSP70 expres-
sion in an allograft contributes to mounting an innate alloim-
mune response cannot be judged in view of these clinical ﬁndings
alone, but a brief look at the more recent literature may help in
interpreting our earlier ﬁndings.
ROLE OF HSP70 FAMILY MEMBERS IN ENHANCING ADAPTIVE IMMUNE
RESPONSES
In general, extracellular HSPs released from damaged cells are
immunogenic and have been shown to enhance TH1 adaptive
immune responses and, therefore, have been used for improved
vaccination procedures against infectious diseases and cancer (for
review, see Binder, 2006). For example, a novel HSP70 family
member, termed Hsp70-like protein 1 (Hsp70L1) was recently
identiﬁed as a potent TH1 polarizing adjuvant that contributes
to antitumor immune responses (Fang et al., 2011). In another
line of experiments on a fusion cell model (DC and tumor cell
fusion), efﬁcient cytotoxic T lymphocyte productivity of modi-
ﬁed fusion cells was demonstrated and supposed to be due to an
up-regulation of HSP70 (Koide et al., 2009).
Such enhancement of adaptive immune responses by HSP70
is thought to be preferentially mediated by its capacity to pro-
motematuration of immunostimulatoryDCs aswell as to enhance
cross-presentation of peptide antigens, that is, a crucial pathway
of exogenous antigen presentation on the HLA class I molecules
by DCs, enabling adaptive antiviral or antitumor responses.
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In fact, in earlier studies, it was already shown that human
HSP70 preparations are able to induce DC maturation (Kupp-
ner et al., 2001; Bethke et al., 2002). In a more recent study on
an in vitro-induced ischemia model, bone marrow–derived DCs
were shown to augment allogeneicT-cell proliferation aswell as the
interferon-gamma response (Jurewicz et al., 2010). In this study,
TLR4 ligation was also shown to occur in ischemic DCs, most
likely – as concluded by the authors – in response to HSP70,which
was found to be elevated in DCs after ischemic injury.
In addition to contributing to the generation of immunostim-
ulatory DCs in terms of a ligand of TLR2/4, extracellular HSP70
has been shown in models of antitumor T-cell responses to pro-
mote the cross-presentation of peptide antigens to MHC class
I molecules in DCs, leading to efﬁcient induction of antigen-
speciﬁc cytotoxic T-lymphocytes (Castelli et al., 2001; Srivas-
tava, 2002; Ueda et al., 2004). Of particular importance for the
discussion of a role of cross-presentation in innate alloimmu-
nity are recent studies demonstrating that HSP70 binds HLA
class I and class II epitope precursors, which further strength-
ens the role of HSP70 in the HLA class I and class II anti-
gen presentation process (Stocki et al., 2010). In fact, these
studies lent support to a more general characteristic of the
HSP70-chaperoned peptides and suggest involvement of HSP70
as a more general phenomenon in the antigen presentation
process.
HEAT SHOCK PROTEINS AND ALLOGRAFT SURVIVAL
Most interesting for our early assumption in 2002/2003 that
HSP70 may be involved in innate alloimmunity would be the
provision of data from experimental studies on allograft mod-
els. However, there are only a few such data published so far and,
unfortunately, they are even controversial. Thus, it could be shown
that targeted gene disruption of the hsp72 gene in donor tissue is
associated with signiﬁcantly but modestly prolonged rejection-
free survival in a murine skin allograft model, the difference
between hsp72-deﬁcient mice and controls being 3 days only (Oh
et al., 2004). Nonetheless, these experimental data suggest that
HSP70 in terms of a pro-inﬂammatory acting DAMP contributes
to an innate alloimmune response although only in a moderate
way.
On the other hand, data from another experimental allograft
model indicate that HSP70 in terms of an anti-inﬂammatory
acting DAMP may even exert a beneﬁcial effect on allograft sur-
vival, although again quite modestly (Borges et al., 2010). In
this study, Mycobacterium tuberculosis HSP70 (TBHSP70) was
shown to inhibit allograft rejection in a skin allograft model
in which the donor skin was immersed in a PBS solution
containing TBHSP70 before transplantation. Interestingly, how-
ever, TBHSP70-induced prolongation of skin allograft survival
was associated with the demonstration of T regulatory cells
(Tregs), a ﬁnding supposed by the authors to mediate the graft-
prolonging effect. Interestingly, the authors discuss (although not
conclusive from their observations) whether or not the Tregs
observed in their studies are speciﬁc for TBHSP70, by refer-
ring to growing evidence in support of the notion that HSPs
possess inherent immunoregulatory properties (van Eden et al.,
2005).
SYNOPSIS
In my opinion, HSPs, since generated in association with any
stressful tissue injury, can be called typical damage-associated
molecular patterns, that is, DAMPs. Their evolutionarily deter-
mined, inherent protective role in concert with a large panoply of
other molecules in commission of the innate immune system lies
in defense against any cell/tissue injury (including elimination of
the injurious agent concerned, e.g., viruses, tumor cells).
In regard to innate alloimmunity, it can be concluded from
our own experience that the expression of HSP70 is moderately
increased in kidneys from brain-dead donors but dramatically up-
regulated after IRI to human renal allografts, thus, fulﬁlling the
criteria of aDAMP.Nomore, no less. However, the exact biological
activity of HSP70 in innate alloimmunity remains elusive.Without
addressing the “contamination debate”here, one may discuss that,
in the excessively inﬂammatory milieu of a postischemically reper-
fused allograft, this DAMP – in concert and collaboration with a
variety of otherDAMPs such asHMGB1 and nucleic acids released
from necrotic graft cells – may operate as an immunity-initiating,
-promoting, and -facilitating stress protein to allograft rejection
[the originally protective role of HSPs here is being converted to
a harmful response from a recipient’s point of view, caused by
a fateful confusion of “invading” foreign antigens (alloantigens)
within an injured organ and foreign antigens derived from invad-
ing dangerous pathogens]. Potential pro-inﬂammatory properties
of HSP70 may lie in its capacities (1) to act as a “priming” DAMP
of the NLRP3 inﬂammasome contributing to the typical inﬂam-
matory environment of a reperfused allograft, (2) to contribute to
maturation of donor- and recipient-derived DCs by engagement
with TLR4/2, and (3) to intensify re-presentation of allopeptides
within donor MHC class II molecules on donor- and recipient-
derived DCs as well as promote cross-presentation of allopeptides
within donor MHC class I molecules on recipient-derived DCs.
In contrast, in a non-injurious or weakly injurious tissue
microenvironment, for example, when HSP70 is added to skin
grafts immersed in culture prior to transplantation (Borges et al.,
2010), this DAMP may elicit negative regulation mechanisms in
graft-containing antigen-presenting cells on the level of TLR sig-
naling. As known, in order to prevent catastrophic host immune
overreactions, such negative feedback regulations exist that con-
trol the intensity and duration of TLR-triggered innate immune
responses – best known as the classic negative regulation in
response to LPS, the “LPS or endotoxin tolerance.” In fact, mol-
ecular feedback inhibitors operating at different levels of TLR-
signaling pathways can be divided into three major groups: extra-
cellular regulators such as soluble decoy TLRs, transmembrane
protein regulators such as the suppressor of tumorigenicity 2, and
intracellular negative regulators such as IL-1 receptor-associated
kinase-M (IRAK-M) and members of the suppressors of cytokine
signaling (SOCS) family (for review, see Land, 2011d).
For example, the well-known anti-inﬂammatory effect of pre-
conditioning procedures including heat preconditioning associ-
ated with the expression of HSP70 (Jo et al., 2006) has been
thought to be due to elicitation of regulatory feedback inhibitors
of TLR signaling (for review, see also Karikó et al., 2004). In
fact, in earlier studies, it was demonstrated that prior expo-
sure to HSP70, here the Toxoplasma gondii-derived HSP70,
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induces a hyporesponse in macrophages to subsequent stim-
ulation with this HSP70 by expression of SOCS1 via TLR4
(Mun et al., 2005). Of note, as shown in more recent stud-
ies on a model of hepatic IRI, preconditioning using the TLR4
agonist LPS elicited the up-regulation of speciﬁc negative reg-
ulators including SOCS1 and IRAK-M in the TLR4-signaling
pathway (Sano et al., 2011). Impressively, molecules operating
in those regulatory feedback loops have been shown to also pre-
vent DC maturation, that is, to promote generation of tolerogenic
DCs known to induce Tregs (for reviews, see Maldonado and
von Andrian, 2010; Land, 2011c). Thus, data from an experi-
mental model of SOCS1-gene overexpression in bone marrow-
derived DCs showed that SOCS1 inhibits DC maturation and
induces generation of regulatory DCs, which – via generation
of CD4+CD25+Tregs – resulted in prolongation of allograft
survival (Fu et al., 2009). First evidence of a similar feedback
inhibiting effect of SOCS2 on TLR-induced activation in human
monocyte-derived DCs has also been recently reported (Posselt
et al., 2011).
Altogether, the context-dependent, even contradistinctive
activities of HSP70 reﬂect the biological phenomenon that,
throughout evolution, mammals have developed an elaborate
network of positive and negative regulatory mechanisms, which
provide balance between defensive measures against dangerous
bacterial and viral pathogens and protective measures against
unwarranted destruction of the host by the activated immune
system. Fine-tuning of TLR signaling in amplitude, space, time,
and character is a key aspect of inﬂammatory reactions in health,
homeostasis, and pathology. What is becoming more and more
apparent is that positive and negative regulators within immune
responses do not work as a single entity, but rather, similar to an
orchestral score, each component is reliant on its other tools such
as HSP70 to produce a harmonious melody instead of a crashing
cacophony.
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